Umbilical cord tissue-derived mesenchymal stem cells for teatment of multiple sclerosis
The aim of this study is to assess the safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (UC-MSCs) administered to multiple sclerosis (MS) patients.
Read More
Translational Biosciences is a subsidiary of Medistem Panama Inc., founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.
Read More
Product Information for
Umbilical cord tissue-derived mesenchymal stem cells for teatment of multiple sclerosis